Literature DB >> 27384268

Risk factors and a clinical prediction model for low maternal thyroid function during early pregnancy: two population-based prospective cohort studies.

Tim I M Korevaar1,2,3, Daan Nieboer4, Peter H L T Bisschop5, Mariette Goddijn6, Marco Medici2,3, Layal Chaker2,3, Yolanda B de Rijke2,7, Vincent W V Jaddoe1,8,9, Theo J Visser2,3, Ewout W Steyerberg4, Henning Tiemeier8,10, Tanja G Vrijkotte11, Robin P Peeters2,3.   

Abstract

BACKGROUND: Low maternal thyroid function during early pregnancy is associated with various adverse outcomes including impaired neurocognitive development of the offspring, premature delivery and abnormal birthweight. AIM: To aid doctors in the risk assessment of thyroid dysfunction during pregnancy, we set out to investigate clinical risk factors and derive a prediction model based on easily obtainable clinical variables.
METHODS: In total, 9767 women during early pregnancy (≤18 week) were selected from two population-based prospective cohorts: the Generation R Study (N = 5985) and the ABCD study (N = 3782). We aimed to investigate the association of easily obtainable clinical subject characteristics such as maternal age, BMI, smoking status, ethnicity, parity and gestational age at blood sampling with the risk of low free thyroxine (FT4) and elevated thyroid stimulating hormone (TSH), determined according to the 2·5th-97·5th reference range in TPOAb negative women.
RESULTS: BMI, nonsmoking and ethnicity were risk factors for elevated TSH levels; however, the discriminative ability was poor (range c-statistic of 0·57-0·60). Sensitivity analysis showed that addition of TPOAbs to the model yielded a c-statistic of 0·73-0·75. Maternal age, BMI, smoking, parity and gestational age at blood sampling were risk factors for low FT4, which taken together provided adequate discrimination (range c-statistic of 0·72-0·76).
CONCLUSIONS: Elevated TSH levels depend predominantly on TPOAb levels, and prediction of elevated TSH levels is not possible with clinical characteristics only. In contrast, the validated clinical prediction model for FT4 had high discriminative value to assess the likelihood of low FT4 levels.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27384268      PMCID: PMC5495157          DOI: 10.1111/cen.13153

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  38 in total

1.  Attitudes of ATA survey respondents toward screening and treatment of hypothyroidism in pregnancy.

Authors:  Pavani Srimatkandada; Alex Stagnaro-Green; Elizabeth N Pearce
Journal:  Thyroid       Date:  2014-12-23       Impact factor: 6.568

Review 2.  Thyroid function in pregnancy: what is normal?

Authors:  Marco Medici; Tim I M Korevaar; W Edward Visser; Theo J Visser; Robin P Peeters
Journal:  Clin Chem       Date:  2015-03-31       Impact factor: 8.327

3.  Universal screening detects two-times more thyroid disorders in early pregnancy than targeted high-risk case finding.

Authors:  Jiri Horacek; Sylvie Spitalnikova; Blanka Dlabalova; Eva Malirova; Jaroslav Vizda; Ioannis Svilias; Jitka Cepkova; Catherine Mc Grath; Jaroslav Maly
Journal:  Eur J Endocrinol       Date:  2010-08-03       Impact factor: 6.664

4.  Screening for thyroid disorders during pregnancy: results of a survey in Maine.

Authors:  James E Haddow; Monica R McClain; Glenn E Palomaki; Edward M Kloza; Josephine Williams
Journal:  Am J Obstet Gynecol       Date:  2006-02       Impact factor: 8.661

5.  Prevalence of thyroid dysfunction in women in early pregnancy: does it increase with maternal age?

Authors:  Marta Diéguez; Ana Herrero; Noelia Avello; Patricio Suárez; Elías Delgado; Edelmiro Menéndez
Journal:  Clin Endocrinol (Oxf)       Date:  2015-01-12       Impact factor: 3.478

6.  Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study.

Authors:  Tim I M Korevaar; Ryan Muetzel; Marco Medici; Layal Chaker; Vincent W V Jaddoe; Yolanda B de Rijke; Eric A P Steegers; Theo J Visser; Tonya White; Henning Tiemeier; Robin P Peeters
Journal:  Lancet Diabetes Endocrinol       Date:  2015-10-20       Impact factor: 32.069

Review 7.  Diagnosis and management of subclinical hypothyroidism in pregnancy.

Authors:  Roberto Negro; Alex Stagnaro-Green
Journal:  BMJ       Date:  2014-10-06

8.  Screening and management of hypothyroidism in pregnancy: results of an Asian survey.

Authors:  Fereidoun Azizi; Atieh Amouzegar; Ladan Mehran; Shahram Alamdari; Imam Subekti; Bijay Vaidya; Kris Poppe; Teofilo San Luis; Takashi Akamizu
Journal:  Endocr J       Date:  2014-05-14       Impact factor: 2.349

9.  Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study.

Authors:  Tim I M Korevaar; Eric A P Steegers; Yolanda B de Rijke; Sarah Schalekamp-Timmermans; W Edward Visser; Albert Hofman; Vincent W V Jaddoe; Henning Tiemeier; Theo J Visser; Marco Medici; Robin P Peeters
Journal:  Eur J Epidemiol       Date:  2015-05-12       Impact factor: 8.082

10.  Screening strategies for thyroid disorders in the first and second trimester of pregnancy in China.

Authors:  Hong Yang; Minglong Shao; Liangmiao Chen; Qingshou Chen; Lechu Yu; Lingqiao Cai; Zhenzhen Lin; Chi Zhang; Xuemian Lu
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

View more
  8 in total

Review 1.  Thyroid disease in pregnancy: new insights in diagnosis and clinical management.

Authors:  Tim I M Korevaar; Marco Medici; Theo J Visser; Robin P Peeters
Journal:  Nat Rev Endocrinol       Date:  2017-08-04       Impact factor: 43.330

2.  Variables Contributing to Thyroid (Dys)Function in Pregnant Women: More than Thyroid Antibodies?

Authors:  Flora Veltri; Kris Poppe
Journal:  Eur Thyroid J       Date:  2018-04-27

3.  Euthyroid Thyroperoxidase Antibody Positivity during Pregnancy, to Treat or Not to Treat?

Authors:  Tim I M Korevaar
Journal:  Endocrinol Metab (Seoul)       Date:  2022-06-29

4.  TSH oscillations in young patients with type 1 diabetes may be due to glycemic variability.

Authors:  G Bellastella; M I Maiorino; L Scappaticcio; O Casciano; M Petrizzo; M Caputo; V A Paglionico; D Giugliano; K Esposito
Journal:  J Endocrinol Invest       Date:  2017-08-30       Impact factor: 4.256

5.  Does foetal gender influence maternal thyroid parameters in pregnancy?

Authors:  Georgiana Sitoris; Flora Veltri; Pierre Kleynen; Malika Ichiche; Serge Rozenberg; Kris G Poppe
Journal:  Eur Thyroid J       Date:  2022-01-01

6.  The Impact of Obesity on Thyroid Autoimmunity and Dysfunction: A Systematic Review and Meta-Analysis.

Authors:  Rong-Hua Song; Bin Wang; Qiu-Ming Yao; Qian Li; Xi Jia; Jin-An Zhang
Journal:  Front Immunol       Date:  2019-10-01       Impact factor: 7.561

7.  Association between thyroid autoimmunity and gestational diabetes mellitus in euthyroid women.

Authors:  Georgiana Sitoris; Flora Veltri; Malika Ichiche; Pierre Kleynen; Jean-Philippe Praet; Serge Rozenberg; Kris G Poppe
Journal:  Eur Thyroid J       Date:  2022-03-21

8.  Short-Term Adverse Pregnancy Outcomes in Women with Subclinical Hypothyroidism: A Comparative Approach of Iranian and American Guidelines.

Authors:  Farahnaz Mir; Hossein Chiti; Saeideh Mazloomzadeh
Journal:  J Thyroid Res       Date:  2022-03-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.